Kappos L, et al. Efficacy and safety of ponesimod compared to teriflunomide in patients with relapsing multiple sclerosis: results of the randomized, active-controlled, double-blind, parallel-group phase 3 OPTIMUM study. Abstract 93. ECTRIMS 2019, 11-13 sept 2019, Stockholm, Zweden.
Epstein-Barr-virus en multipele sclerose: een causaal verband?
feb 2022 | Multipele Sclerose, Virale infecties